The insider sales are small and pre-planned, carrying no negative signal. Monitor next quarter for RASONQUE revenue trajectory and any insider buying that would indicate conviction.
RVMD drugs
RVMD drug pipeline →Price Chart
How similar events traded
Executive Summary
Two insiders at Revolution Medicines sold shares in the week following Q3 earnings that showed RASONQUE revenue far exceeding consensus. CFO Anders Jack sold $633K and Anthony Mancini sold $162K, both under 10b5-1 plans. The total open-market sales of ~$796K represent ~0.002% of the $39.1B market cap, a trivial amount that does not alter the positive earnings read-through.
Key Financial Metrics
Key Facts
- CFO Anders Jack sold 3,500 shares at $181.04 for $633K on 2026-11-11 under a 10b5-1 plan
- Anthony Mancini sold 811 shares at $200.00 for $162K on 2026-11-09 under a 10b5-1 plan
- Total open-market sales of ~$796K represent ~0.002% of the $39.1B market cap
- Sales occurred 5-7 days after Q3 earnings showing RASONQUE revenue of $197.6M vs consensus $27.3M
- Both sales were pre-planned under 10b5-1 trading plans, reducing informational content
Financial Impact
~$796K in open-market sales, immaterial relative to $39.1B market cap
Risk Factors
- Insider sales are trivial in size and under 10b5-1 plans, so no material risk signal
- No risk to current positive earnings narrative from this cluster
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RVMD-1794610841253 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Viewing Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers